Sanofi (SNY)
48.06
+0.34
(+0.71%)
USD |
NASDAQ |
Apr 17, 16:00
48.08
+0.02
(+0.04%)
After-Hours: 20:00
Sanofi Enterprise Value : 126.44B for April 17, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cellectis SA | 355.85M |
| Novavax, Inc. | 972.44M |
| Regeneron Pharmaceuticals, Inc. | 73.71B |
| BioNTech SE | 8.912B |
| Moderna, Inc. | 16.81B |
Enterprise Value Related Metrics
| Earnings Yield | 4.97% |
| Operating Earnings Yield | 10.99% |
| Normalized Earnings Yield | 7.393 |